C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/05/2002	CA2484900A1 Process of producing environmentally safe transgenic organisms
12/05/2002	CA2479984A1 Amplification vectors based on trans-splicing
12/05/2002	CA2454557A1 Callus specific plant promoters
12/05/2002	CA2449127A1 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
12/05/2002	CA2449029A1 Modification of plant genomes by inducible site-specific recombination of trans genes
12/05/2002	CA2449020A1 Microstructures and use thereof for the directed evolution of biomolecules
12/05/2002	CA2449014A1 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
12/05/2002	CA2449004A1 Melanin-concentrating hormone analogs
12/05/2002	CA2449000A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	CA2448985A1 Gene delivery via a baculovirus vector
12/05/2002	CA2448983A1 Cloning vectors for homologous recombination and method using same
12/05/2002	CA2448963A1 Pharmaceutical use for secreted bacterial effector proteins
12/05/2002	CA2448757A1 Accurate and efficient quantification of dna sensitivity by real-time pcr
12/05/2002	CA2448711A1 Use of duckweed in high throughput screening
12/05/2002	CA2448628A1 Compositions and methods for random nucleic acid mutagenesis
12/05/2002	CA2448620A1 Vaccination against the feline immunodeficiency virus
12/05/2002	CA2448569A1 Compositions and methods for the inference of pigmentation traits
12/05/2002	CA2448567A1 Modulators of nucleic acid ligands
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/05/2002	CA2448320A1 Ribozyme based treatment of female reproductive diseases
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448146A1 Secreted proteins
12/05/2002	CA2448116A1 Molecules for disease detection and treatment
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2448104A1 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	CA2448096A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
12/05/2002	CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	CA2447916A1 Tumor endothelial marker 7.alpha. molecules and uses thereof
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2447849A1 Constitutive plant promotor
12/05/2002	CA2447662A1 Transporters and ion channels
12/05/2002	CA2447629A1 The lectin-like domain of thrombomodulin and its therapeutic use
12/05/2002	CA2447463A1 A quantitative hybridization assay for the analysis of nucleic acid
12/05/2002	CA2445611A1 P-cadherin as a target for anti-cancer therapy
12/05/2002	CA2443821A1 Transgenic plants with reduced adenylate kinase activity showing an increased accumulation of starch
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/05/2002	CA2442705A1 Molecules for diagnostics and therapeutics
12/05/2002	CA2441937A1 Chromosome-based platforms
12/04/2002	EP1262565A2 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
12/04/2002	EP1262564A2 Dna sequencing by mass spectrometry
12/04/2002	EP1262562A2 Actinomycetes polynucleotides
12/04/2002	EP1262560A2 Method of forming cDNA from an RNA target sequence present in a sample
12/04/2002	EP1262556A2 Antimicrobial peptides and method for identifying and using such peptides
12/04/2002	EP1262555A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells
12/04/2002	EP1262554A2 Defective packaging non-oncoviral vectors based on mpmv and hiv
12/04/2002	EP1262552A1 Polynucleotides encoding insect glutaminyl cyclase and uses thereof
12/04/2002	EP1262551A2 A sorbitol dehydrogenase gene, a recombinant DNA, and a process for producing sorbitol dehydrogenase
12/04/2002	EP1262550A2 (R)-2,3-butanediol dehydrogenase, methods for producing same, and methods for producing optically active alcohol using the dehydrogenase
12/04/2002	EP1262548A1 Polypeptide inducing apoptosis
12/04/2002	EP1262547A1 Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma
12/04/2002	EP1262546A1 Novel scavenger receptors
12/04/2002	EP1262545A1 Microstructures and the use thereof in the targeted evolution of biomolecules
12/04/2002	EP1262541A1 Production of bioavailable folic acid
12/04/2002	EP1262491A2 Non-anaphylactogenic IgE vaccines
12/04/2002	EP1262489A1 Complex comprising recombinant ferritin and a precious metal and DNA encoding said ferritin
12/04/2002	EP1262486A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof
12/04/2002	EP1262478A2 Methods and compositions for determining cellular response profiles
12/04/2002	EP1262199A1 Vectors for enhanced expression of VEGF for disease treatment
12/04/2002	EP1262191A1 Pharmaceutical compositions comprising recombinant human acid alpha-glucosidase containing mannose 6-phosphate
12/04/2002	EP1262190A1 Rfrp-containing prolactin secretion regulatory agent
12/04/2002	EP1261932A2 Methods for generating databases and databases for identifying polymorphic genetic markers
12/04/2002	EP1261874A1 Specific monoclonal antibody against terbinafine
12/04/2002	EP1261873A1 Compositions and methods for surface imprinting
12/04/2002	EP1261871A1 Methods and compositions for identifying ligands for nuclear receptors
12/04/2002	EP1261863A2 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
12/04/2002	EP1261745A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261744A2 Estrogen receptor beta variants and methods of detection thereof
12/04/2002	EP1261742A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261740A1 Ligase/polymerase method for detecting cytosine methylation in dna samples
12/04/2002	EP1261736A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides
12/04/2002	EP1261734A1 GENOMIC ANALYSIS OF tRNA GENE SETS
12/04/2002	EP1261731A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
12/04/2002	EP1261730A2 A process for generating cytoplasmic male sterile line in rice and other crops by rna editing
12/04/2002	EP1261729A2 A process for generating genetically modified pearl millet through agrobacterium and biolistic transformation
12/04/2002	EP1261728A2 Plant internal ribosome entry segment
12/04/2002	EP1261727A2 Transgenic plants with increased seed yield, biomass and harvest index
12/04/2002	EP1261726A1 Transgenic trees exhibiting increased growth, biomass production and xylem fibre length, and methods for their production
12/04/2002	EP1261725A2 Methods and constructs for agrobacterium-mediated plant transformation
12/04/2002	EP1261724A1 Topoisomerase linker-mediated amplification methods
12/04/2002	EP1261723A2 Hybrid expression of neisserial proteins
12/04/2002	EP1261722A2 18036, a novel calpain-like protease and uses thereof
12/04/2002	EP1261721A1 Human extracellular signal regulated kinases
12/04/2002	EP1261720A2 Cell cycle proteins associated with rad9, compositions and methods of use
12/04/2002	EP1261718A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
12/04/2002	EP1261717A2 Mutant bacterial strains of the genus sphingonomas deficient in production of polyhydroxybutyrate and a process of clarification of sphingans
12/04/2002	EP1261716A2 Method for rapid and accurate identification of microorganisms
12/04/2002	EP1261715A2 Monocotyledonous plant genes and uses thereof
12/04/2002	EP1261714A2 Muteins of interleukin-13 (il-13)
12/04/2002	EP1261713A2 Human ion channels
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261711A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma
12/04/2002	EP1261710A2 G protein-coupled receptors
12/04/2002	EP1261709A1 Human abc transporter expressed in liver, atil
12/04/2002	EP1261708A2 Compositions and methods for the therapy and diagnosis of prostate cancer
12/04/2002	EP1261707A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
12/04/2002	EP1261706A2 Egg specific surface proteins
12/04/2002	EP1261705A2 Methods and compositions for screening using diphtheria toxin constructs
12/04/2002	EP1261704A2 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
12/04/2002	EP1261703A1 Nucleic acids, proteins, and antibodies

1 ... 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 ... 4023